UA91497C2 - ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА - Google Patents

ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА

Info

Publication number
UA91497C2
UA91497C2 UAA200604047A UAA200604047A UA91497C2 UA 91497 C2 UA91497 C2 UA 91497C2 UA A200604047 A UAA200604047 A UA A200604047A UA A200604047 A UAA200604047 A UA A200604047A UA 91497 C2 UA91497 C2 UA 91497C2
Authority
UA
Ukraine
Prior art keywords
moiety
denotes
shock
peptide
alpha
Prior art date
Application number
UAA200604047A
Other languages
English (en)
Ukrainian (uk)
Inventor
Петер Петцельбауер
Кай Захаровски
Original Assignee
Фибрекс Медикел Рисеч & Девелопмент Гезмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фибрекс Медикел Рисеч & Девелопмент Гезмбх filed Critical Фибрекс Медикел Рисеч & Девелопмент Гезмбх
Publication of UA91497C2 publication Critical patent/UA91497C2/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Изобретение относится к применению пептида общей формулы IIгдеRи R, одинаковые или разные, представляют водород, насыщенную или ненасыщенную углеводородную часть, которая содержит от 1 до 10 атомов углерода,Z- гистидиновая или пролиновая часть,Arg - аргининовая часть,Z- пролиновая или валиновая часть,Z- лейциновая или валиновая часть,Z- пептидная часть, полученная из цепи Вβ фибрина,причем пептид биологически способен соответствовать индуцированной связующей VЕ-кадгерин части цепи Вβ ( то есть Вβ) человеческого фибрина, для изготовления фармацевтического препарата для лечения шока.
UAA200604047A 2004-06-25 2005-06-24 ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА UA91497C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0108704A AT414097B (de) 2004-06-25 2004-06-25 Pharmazeutische zubereitung zur behandlung von schock

Publications (1)

Publication Number Publication Date
UA91497C2 true UA91497C2 (ru) 2010-08-10

Family

ID=35508712

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200604047A UA91497C2 (ru) 2004-06-25 2005-06-24 ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА

Country Status (4)

Country Link
CN (1) CN1842344A (ru)
AT (1) AT414097B (ru)
UA (1) UA91497C2 (ru)
ZA (1) ZA200602053B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT502987A1 (de) 2005-12-23 2007-07-15 Fibrex Medical Res & Dev Gmbh Pharmazeutische zusammensetzung zur behandlung von hämorrhagischem schock und seinen folgeerscheinungen
CN101937002A (zh) * 2010-07-23 2011-01-05 合肥天一生物技术研究所 血红蛋白目测试剂
US20150037354A1 (en) * 2012-03-15 2015-02-05 The Resesrch Foundation for The State University of New York Combination therapies including inhibitors of the extracellular domain of e-cadherin

Also Published As

Publication number Publication date
AT414097B (de) 2006-09-15
CN1842344A (zh) 2006-10-04
ATA10872004A (de) 2005-12-15
ZA200602053B (en) 2007-06-27

Similar Documents

Publication Publication Date Title
IL173969A0 (en) Use of peptides derived from the a alpha or b beta chain of human of human fibrinogen for the treatment of shock
WO2006113681A3 (en) Plant-derived elastin binding protein ligands and methods of using the same
DK0750506T3 (da) Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse
AR062065A1 (es) Anticuerpo humanizado
AR036196A1 (es) Agentes de contraste multimericos dirigidos a base de peptidos
NZ593815A (en) Tissue factor pathway inhibitor (tfpi) inhibitors and methods of use
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
WO2005116051A3 (de) An mhc-moleküle bindende tumor-assoziierte peptide
AU2003264419A1 (en) Kdr peptides and vaccines containing the same
WO2009004315A8 (en) Isolated peptides and uses thereof
WO2005097828A3 (en) Peptides of cav2.2 that inhibit pain
EP1071443A4 (en) ISOLATED PEPTIDES CORRESPOND THE NY-ESO-1 AMINO ACID SEQUENCES AND BIND TO MHC CLASS I AND MHC CLASS II MOLECULES AND THEIR USE
ATE455792T1 (de) Neues phosphatbindendes protein, pharmazeutische zusammensetzungen, die dieses enthalten, und verwendung davon
UA91497C2 (ru) ПРИМЕНЕНИЕ ПЕПТИДОВ, ВЫДЕЛЕННЫХ ИЗ ЦЕПИ Bb ЧЕЛОВЕЧЕСКОГО ФИБРИНОГЕНА, ДЛЯ ЛЕЧЕНИЯ ШОКА
YU53803A (sh) Peptidi i/ili proteini kao i njihova primena za pripremanje terapeutskih i/ili preventivnih lekova
WO2007013358A3 (en) Vivit polypeptides, therapeutic agent comprising the same, and method of screening for anti-cancer agent
EP1796707A4 (en) PEPTIDES WITH SPECIFIC SEAT IN HEART VESSELS AND RELATED CONJUGATES AND METHOD
DE602006017806D1 (de) Behandlung von neurodegeneration
AR026068A1 (es) Peptidos modificados y peptidomimeticos para el uso en inmunoterapia.
WO2005087809B1 (en) Peptides from vitronectin and their therapeutic exploitation for osteoblast adhesion
PL1625152T3 (pl) Peptydy modelujące aktywność czynnika transkrypcyjnego Engrailed
EP1724346A3 (de) An die Lck-SH3 und Hck-SH3 Domäne bindende Peptide
WO2022200327A3 (de) Verwendung von d-enantiomeren peptidliganden von monomerem a-synuclein für die therapie verschiedener synucleinopathien
IL151211A0 (en) Compositions useful for regulating parkin gene activity
HK1083850A1 (en) Peptides binding the phosphatase 2a protein and polynucleotides encoding same